238 related articles for article (PubMed ID: 16343579)
21. [Epstein-Barr Virus Genome Replication as a Molecular Target for Cancer Therapy].
Noguchi K
Yakugaku Zasshi; 2019; 139(1):63-67. PubMed ID: 30606931
[TBL] [Abstract][Full Text] [Related]
22. The Hsp70 inhibitor 2-phenylethynesulfonamide inhibits replication and carcinogenicity of Epstein-Barr virus by inhibiting the molecular chaperone function of Hsp70.
Wang H; Bu L; Wang C; Zhang Y; Zhou H; Zhang X; Guo W; Long C; Guo D; Sun X
Cell Death Dis; 2018 Jun; 9(7):734. PubMed ID: 29959331
[TBL] [Abstract][Full Text] [Related]
23. Relative levels of EBNA1 gene transcripts from the C/W, F and Q promoters in Epstein-Barr virus-transformed lymphoid cells in latent and lytic stages of infection.
Zetterberg H; Stenglein M; Jansson A; Ricksten A; Rymo L
J Gen Virol; 1999 Feb; 80 ( Pt 2)():457-466. PubMed ID: 10073708
[TBL] [Abstract][Full Text] [Related]
24. EBNA1 regulates cellular gene expression by binding cellular promoters.
Canaan A; Haviv I; Urban AE; Schulz VP; Hartman S; Zhang Z; Palejev D; Deisseroth AB; Lacy J; Snyder M; Gerstein M; Weissman SM
Proc Natl Acad Sci U S A; 2009 Dec; 106(52):22421-6. PubMed ID: 20080792
[TBL] [Abstract][Full Text] [Related]
25. Targeted disruption of EBNA1 in EBV-infected cells attenuated cell growth.
Noh KW; Park J; Kang MS
BMB Rep; 2016 Apr; 49(4):226-31. PubMed ID: 26879316
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the EBNA1 proteins of Epstein-Barr virus and herpesvirus papio in sequence and function.
Yates JL; Camiolo SM; Ali S; Ying A
Virology; 1996 Aug; 222(1):1-13. PubMed ID: 8806482
[TBL] [Abstract][Full Text] [Related]
27. The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfold.
Humme S; Reisbach G; Feederle R; Delecluse HJ; Bousset K; Hammerschmidt W; Schepers A
Proc Natl Acad Sci U S A; 2003 Sep; 100(19):10989-94. PubMed ID: 12947043
[TBL] [Abstract][Full Text] [Related]
28. GAP31 from an ancient medicinal plant exhibits anti-viral activity through targeting to Epstein-Barr virus nuclear antigen 1.
Shen CL; Huang WH; Hsu HJ; Yang JH; Peng CW
Antiviral Res; 2019 Apr; 164():123-130. PubMed ID: 30817940
[TBL] [Abstract][Full Text] [Related]
29. [Therapeutic inhibition of Epstein-Barr virus-associated tumor cell growth by dominant-negative EBNA1].
Imai S; Kuroda M; Yamashita R; Ishiura Y
Uirusu; 2005 Dec; 55(2):239-49. PubMed ID: 16557009
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of antigen presentation by the glycine/alanine repeat domain is not conserved in simian homologues of Epstein-Barr virus nuclear antigen 1.
Blake NW; Moghaddam A; Rao P; Kaur A; Glickman R; Cho YG; Marchini A; Haigh T; Johnson RP; Rickinson AB; Wang F
J Virol; 1999 Sep; 73(9):7381-9. PubMed ID: 10438828
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus-encoded EBNA1 and ZEBRA: targets for therapeutic strategies against EBV-carrying cancers.
Daskalogianni C; Pyndiah S; Apcher S; Mazars A; Manoury B; Ammari N; Nylander K; Voisset C; Blondel M; Fåhraeus R
J Pathol; 2015 Jan; 235(2):334-41. PubMed ID: 25186125
[TBL] [Abstract][Full Text] [Related]
32. EGCG debilitates the persistence of EBV latency by reducing the DNA binding potency of nuclear antigen 1.
Chen YL; Tsai HL; Peng CW
Biochem Biophys Res Commun; 2012 Jan; 417(3):1093-9. PubMed ID: 22226960
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr Virus nuclear antigen 1 (EBNA1) confers resistance to apoptosis in EBV-positive B-lymphoma cells through up-regulation of survivin.
Lu J; Murakami M; Verma SC; Cai Q; Haldar S; Kaul R; Wasik MA; Middeldorp J; Robertson ES
Virology; 2011 Feb; 410(1):64-75. PubMed ID: 21093004
[TBL] [Abstract][Full Text] [Related]
34. Nucleolin directly mediates Epstein-Barr virus immune evasion through binding to G-quadruplexes of EBNA1 mRNA.
Lista MJ; Martins RP; Billant O; Contesse MA; Findakly S; Pochard P; Daskalogianni C; Beauvineau C; Guetta C; Jamin C; Teulade-Fichou MP; Fåhraeus R; Voisset C; Blondel M
Nat Commun; 2017 Jul; 8():16043. PubMed ID: 28685753
[TBL] [Abstract][Full Text] [Related]
35. EBP2, a human protein that interacts with sequences of the Epstein-Barr virus nuclear antigen 1 important for plasmid maintenance.
Shire K; Ceccarelli DF; Avolio-Hunter TM; Frappier L
J Virol; 1999 Apr; 73(4):2587-95. PubMed ID: 10074103
[TBL] [Abstract][Full Text] [Related]
36. Protein array identification of substrates of the Epstein-Barr virus protein kinase BGLF4.
Zhu J; Liao G; Shan L; Zhang J; Chen MR; Hayward GS; Hayward SD; Desai P; Zhu H
J Virol; 2009 May; 83(10):5219-31. PubMed ID: 19244323
[TBL] [Abstract][Full Text] [Related]
37. Berberine inhibits the proliferation of human nasopharyngeal carcinoma cells via an Epstein-Barr virus nuclear antigen 1-dependent mechanism.
Wang C; Wang H; Zhang Y; Guo W; Long C; Wang J; Liu L; Sun X
Oncol Rep; 2017 Apr; 37(4):2109-2120. PubMed ID: 28259949
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of Epstein-Barr virus replication by small interfering RNA targeting the Epstein-Barr virus protease gene.
Larrat S; Morand P; Bas A; Vigne S; Crance JM; Boyer V; Nicod S; Grossi L; Buisson M; Burmeister WP; Seigneurin JM; Germi R
Antivir Ther; 2009; 14(5):655-62. PubMed ID: 19704168
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus nuclear antigen 1 interacts with Nm23-H1 in lymphoblastoid cell lines and inhibits its ability to suppress cell migration.
Murakami M; Lan K; Subramanian C; Robertson ES
J Virol; 2005 Feb; 79(3):1559-68. PubMed ID: 15650182
[TBL] [Abstract][Full Text] [Related]
40. Nucleolin is important for Epstein-Barr virus nuclear antigen 1-mediated episome binding, maintenance, and transcription.
Chen YL; Liu CD; Cheng CP; Zhao B; Hsu HJ; Shen CL; Chiu SJ; Kieff E; Peng CW
Proc Natl Acad Sci U S A; 2014 Jan; 111(1):243-8. PubMed ID: 24344309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
